Early-stage funding for European life sciences companies

We are a venture capital firm specialised in seed investment for innovative early stage companies. BGV generally acts as lead investor. Our current portfolio comprises of biotech developing truly disruptive solutions for high unmet medical needs.

Acerta, a multi-billion Euro success story

BioGeneration was co-founder and investor in the most successful biotech startup in Europe: Acerta Pharma. Acerta Pharma has developed Calquence® (acalabrutinib), a drug now approved by the FDA for the treatment of hematologic malignancies (leukemia). Acerta was sold to AstraZeneca for up to US$ 7 billion in 2016.

Shaping new life-science ventures

We gained our experience from working within small and large pharma and biotech companies. Based on this experience and through our extensive industry network, we are able to bring a range of sector-relevant expertise to help accelerate product development and shape the companies to become attractive investment opportunities for the industry.

Latest news

BGV Expands Team with the Appointment of a Partner and Venture Partner

Naarden, The Netherlands, 14 September 2021 – BioGeneration Ventures (“BGV”), a leading early-stage VC in European biopharma, today announces the appointment of Keno Gutierrez as Partner, and Wouter Verhoeven as Venture Partner. Collectively these two appointments...

Kyowa Kirin Taps Synaffix ADC Technology to Expand Its Pipeline

Synaffix will provide all necessary proprietary ADC technologies, including GlycoConnect™, HydraSpace™, and select toxSYN™ linker-payloads Kyowa Kirin will leverage its innovative antibody-based therapeutics pipeline to develop a portfolio of ADCs with optimized...

Next events

16 – 21 September EMSO Congress 2021

The ESMO (European Society for Medical Oncology) Congress is the most influential oncology platform designed in Europe for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world. 

19 September Sachs 20th Annual Biotech in Europe Forum

The 20th Annual Biotech in Europe (BEF) Forum is recognised as the leading international Stage for those interested in investing and partnering in the biotech and life science industry. This highly transactional event draws together an exciting cross-section of...

20 – 22 September Nordic Innovation Fair

The Nordic Innovation Fair will showcase more than 120 business opportunities, offering a free and unique matchmaking and networking opportunity by bringing together all stakeholders across the innovation ecosystem. Researchers and spinouts from Sweden, Norway,...

Latest investments

Subscribe to BGV news updates

Join our mailing list to receive the latest news and updates from our team.

Privacy Policy

Please check your email to complete your subscription.